Patents by Inventor Marc Revés Vilaplana

Marc Revés Vilaplana has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heteroaryl compounds and their use
    Patent number: 11739072
    Abstract: The application is directed to compounds of formula (I): and their salts and solvates, wherein R1, R2, R3, A1, A2, A3, and n are as set forth in the specification, as well as to a method for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or prevention of a lysosomal storage disease, such as Gaucher's, and other diseases or disorders that are synucleinopathies.
    Type: Grant
    Filed: October 6, 2021
    Date of Patent: August 29, 2023
    Assignee: Minoryx Therapeutics S.L.
    Inventors: Ana Maria García Collazo, Xavier Barril Alonso, Elena Cubero Jordà, Marc Revés Vilaplana, Richard Spurring Roberts
  • HETEROARYL COMPOUNDS AND THEIR USE
    Publication number: 20220135535
    Abstract: The application is directed to compounds of formula (I): and their salts and solvates, wherein R1, R2, R3, A1, A2, A3, and n are as set forth in the specification, as well as to a method for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or prevention of a lysosomal storage disease, such as Gaucher's, and other diseases or disorders that are synucleinopathies.
    Type: Application
    Filed: October 6, 2021
    Publication date: May 5, 2022
    Applicant: Minoryx Therapeutics S.L.
    Inventors: Ana Maria García Collazo, Xavier Barril Alonso, Elena Cubero Jordà, Marc Revés Vilaplana, Richard Spurring Roberts
  • Heteroaryl compounds and their use
    Patent number: 11174242
    Abstract: The application is directed to compounds of formula (I): and their salts and solvates, wherein R1, R2, R3, A1, A2, A3, and n are as set forth in the specification, as well as to a method for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or prevention of a lysosomal storage disease, such as Gaucher's, and other diseases or disorders that are synucleinopathies.
    Type: Grant
    Filed: December 28, 2017
    Date of Patent: November 16, 2021
    Assignee: Minoryx Therapeutics S.L.
    Inventors: Ana Maria García Collazo, Xavier Barril Alonso, Elena Cubero Jordà, Marc Revés Vilaplana, Richard Spurring Roberts
  • HETEROARYL COMPOUNDS AND THEIR USE
    Publication number: 20190337922
    Abstract: The application is directed to compounds of formula (I): and their salts and solvates, wherein R1, R2, R3, A1, A2, A3, and n are as set forth in the specification, as well as to a method for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or prevention of a lysosomal storage disease, such as Gaucher's, and other diseases or disorders that are synucleinopathies.
    Type: Application
    Filed: December 28, 2017
    Publication date: November 7, 2019
    Applicant: Minoryx Therapeutics S.L.
    Inventors: Ana Maria GARCÍA COLLAZO, Xavier BARRIL ALONSO, Elena CUBERO JORDÀ, Marc REVÉS VILAPLANA, Richard Spurring ROBERTS
  • DI(HETERO)ARYLAMIDES AND SULFONAMIDES, METHODS FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF
    Publication number: 20160168132
    Abstract: The present invention refers to compounds of formula (I): as well as to a method for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or prevention of conditions associated with the alteration of the activity of ?-galactosidase, specially galactosidase beta-1 or GLB1, including GM1 gangliosidoses and Morquio syndrome, type B.
    Type: Application
    Filed: July 30, 2014
    Publication date: June 16, 2016
    Applicant: Minoryx Therapeutics S.L.
    Inventors: Xavier BARRIL ALONSO, Ana Maria GARCÍA COLLAZO, Juan AYMAMI BOFARULL, Marc REVÉS VILAPLANA, Rodolfo LAVILLA GRIFOLS, Marc MARTINELL PEDEMONTE
  • Enantiomerically Enriched Aminodiphosphines as Ligands for the Preparation of Catalysts for Asymmetric Synthesis
    Publication number: 20120309997
    Abstract: The present invention relates to enantiomerically enriched aminodiphosphine ligands where the chirality is located in the phosphorus atom and their preparation process, to catalysts containing them and their preparation process, as well as their use in asymmetric synthesis.
    Type: Application
    Filed: October 13, 2010
    Publication date: December 6, 2012
    Applicant: ENANTIA, S.L.
    Inventors: Mónica Alonso Xalma, Xavier Verdaguer Espaulella, Marc Revés Vilaplana, Antoni Riera Escalé